The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Platelet-activating Factor Acetylhydrolases
Open accessAbstract
Platelet-activating factor acetylhydrolases are structurally diverse isoenzymes that catalyze the hydrolysis of the acyl group at the second position of glycerol in unusual, bioactive phospholipids (Fig. 1). Thus, as categorized by enzymatic activity, they are phospholipases A2 (Groups VII and VIII, Ref. 1), which often initiate signal transduction and are regulated by the state of the cell activation. However, the platelet-activating factor (PAF,1 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) acetylhydrolases have the opposite role; they were discovered by investigators who focused on the inactivation of PAF (2).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prescott, S. M., Zimmerman, G. A., & McIntyre, T. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38167-5 · Cited by 889
Self-citationThe growing phospholipase A2 superfamily of signal transduction enzymes
Dennis, E. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)20031-3 · Cited by 802
Anti-inflammatory properties of a platelet-activating factor acetylhydrolase
Tjoelker, L. W., Wilder, C., Eberhardt, C., Stafforinit, D. M., Dietsch, G., Schimpf, B., Hooper, S., Trong, H. L., Cousens, L. S., Zimmerman, G. A., et al. (1995) · Nature · doi:10.1038/374549a0 · Cited by 526
Self-citationPalinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.605 · Cited by 488
Inflammation: Basic Principles and Clinical Correlates
Fawthrop, F. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.10.701-b · Cited by 482
Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor
Hattori, M., Adachi, H., Tsujimoto, M., Arai, H., & Inoue, K. (1994) · Nature · doi:10.1038/370216a0 · Cited by 469
Watson, A. D., Navab, M., Hama, S. Y., Sevanian, A., Prescott, S. M., Stafforini, D. M., McIntyre, T. M., Du, B. N., Fogelman, A. M., & Berliner, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117726 · Cited by 403
Self-citationStafforini, D. M., McIntyre, T. M., Carter, M. E., & Prescott, S. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61335-3 · Cited by 398
Self-citationHeery, J. M., Kozak, M., Stafforini, D. M., Jones, D. A., Zimmerman, G. A., McIntyre, T. M., & Prescott, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118288 · Cited by 306
Self-citationMiwa, M., Miyake, T., Yamanaka, T., Sugatani, J., Suzuki, Y., Sakata, S., Araki, Y., & Matsumoto, M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113818 · Cited by 279
Cited by
The expanding superfamily of phospholipase A2 enzymes: classification and characterization
Six, D. A., & Dennis, E. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00105-0 · Cited by 1,358
Kudo, I., & Murakami, M. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00020-5 · Cited by 757
Platelet-Activating Factor and Related Lipid Mediators
Prescott, S. M., Zimmerman, G. A., Stafforini, D. M., & McIntyre, T. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.419 · Cited by 748
Self-citationREGULATION AND INHIBITION OF PHOSPHOLIPASE A2
Balsinde, J., Balboa, M. A., Insel, P. A., & Dennis, E. A. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.175 · Cited by 566
Recent progress in phospholipase A2 research: From cells to animals to humans
Murakami, M., Taketomi, Y., Miki, Y., Sato, H., Hirabayashi, T., & Yamamoto, K. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.12.001 · Cited by 507
Zalewski, A., & Macphee, C. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 474
Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins
Khovidhunkit, Memon, R. A., Feingold, K. R., & Grunfeld, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315611 · Cited by 403
Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
Ishii, S., & Shimizu, T. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(99)00016-8 · Cited by 384
Zimmerman, G. A., McIntyre, T. M., Prescott, S. M., & Stafforini, D. M. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205001-00020 · Cited by 358
Self-citationOxidative stress and neutrophil activation—the two keystones of ischemia/reperfusion injury
Kaminski, K. A., Bonda, T. A., Korecki, J., & Musial, W. J. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00189-4 · Cited by 340
Peloso, G. M., Auer, P. L., Bis, J. C., Voorman, A., Morrison, A. C., Stitziel, N. O., Brody, J. A., Khetarpal, S. A., Crosby, J. R., Fornage, M., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.01.009 · Cited by 317
Kolodgie, F. D., Burke, A. P., Skorija, K. S., Ladich, E., Kutys, R., Makuria, A. T., & Virmani, R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000244681.72738.bc · Cited by 309
Inflammatory Markers of Coronary Risk
Rader, D. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431609 · Cited by 260
Novel biomarkers for cardiovascular risk prediction.
Wang, J., Tan, G.-J., Han, L.-N., Bai, Y., He, M., & Liu, H. (2017) · PubMed · doi:10.11909/j.issn.1671-5411.2017.02.008 · Cited by 256
Review of four major distinct types of human phospholipase A2
Vasquez, A. M., Mouchlis, V. D., & Dennis, E. A. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.10.009 · Cited by 114
Metadata
- Authors
- Stafforini, D. M., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-07
- Volume
- 272
- Issue
- 29
- Pages
- 17895-17898
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1997397222
- Cited by
- 270
- References
- 33
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.